Navigation Links
On the trail of a vaccine for Lyme disease: Yale researchers target tick saliva
Date:11/19/2009

New Haven, Conn. A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites.

Traditionally, vaccines have directly targeted specific pathogens. This is the first time that antibodies against a protein in the saliva of a pathogen's transmitting agent (in this case, the tick) has been shown to confer immunity when administered protectively as a vaccine.

The Lyme bacterium known as Borrelia burgdorferi is transmitted by ticks. When it moves through the tick, it is coated with a tick salivary protein known as Salp15. The Yale team injected Salp15 into healthy mice and found that it significantly protected them from getting Lyme disease. When combined with outer surface proteins of B. burgdorferi, the protection was even greater.

Lead author Erol Fikrig, M.D. of Yale School of Medicine and Howard Hughes Medical Institute said, "The interaction between the Lyme disease agent and ticks is very complex, and the bacteria uses a tick salivary protein to facilitate infection of the mammalian host. By interfering with this important interaction, we can influence infection by the Lyme disease agent."

Several years ago there was a Lyme vaccine on the market that utilized just the outer surface proteins of the bacteria. It was taken off the market in 2002, and to date no other antigen has been tested in phase III clinical trials.

The authors believe this new strategy of targeting the saliva - the "vector molecule" that a microbe requires to infect a host - may be applicable not just to Lyme disease but to other insect-borne pathogens that also cause human illness.

"We believe that it is likely that many arthropod-borne infection agents of medical importance use vector proteins as they move to the mammalian host," Fikrig explained. "If so, then this paradigm, described with the Lyme disease agent, is likely to be applicable to these illnesses. Currently, we are working to determine if this strategy is likely to be important for West Nile virus infection, dengue fever, and malaria, among other diseases."


'/>"/>

Contact: Helen Dodson
helen.dodson@yale.edu
203-436-3984
Yale University
Source:Eurekalert  

Related medicine news :

1. Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer
2. University of Leicester cancer researchers investigate smoking gun trail
3. MEDRAD Mobile MR Injector Meets Challenges of MR Trailers
4. Thompson Demands Solution to Formaldehyde Trailer Crisis
5. Smiling on the Campaign Trail - Cosmetic Dentist Michael Kosdon Rates the Candidates
6. TrailBlazer Announces Final Medicare Administrative Contractor Schedule for Claims Processing in Four States
7. Stress On The Campaign Trail, One Issue All The Candidates Agree On
8. What Drives Hillary to Get Up Every Morning and Hit the Campaign Trail?
9. AVMA Opposes Use of Double-Deck Trailers for Transporting Horses and Other Equines
10. Scientists Hot on Trail of New Antibiotics
11. The Age Factor on the Campaign Trail: When the Going Gets Tough, the Tough Keep Moving
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
On the trail of a vaccine for Lyme disease: Yale researchers target tick saliva
(Date:7/26/2017)... ... July 26, 2017 , ... ... and in the cloud ; today announced the availability of its latest data ... simple to use control console for Data Discovery, Classification, Encryption and Digital Rights ...
(Date:7/26/2017)... ... ... “We are thrilled to be partnering with Six Month Smiles to work ... in real time,” said Keith English, LocalMed CEO. “Allowing patients the ability to schedule ... Month Smiles patients to their providers.” , Each month, over 25,000 patients research Six ...
(Date:7/26/2017)... Michigan (PRWEB) , ... July 26, 2017 , ... ... appointed Medical Director for the treatment program located in Royal Oak, Michigan. ... of investors who are focused on providing the highest standards in the field of ...
(Date:7/26/2017)... ... 2017 , ... The Amnesty Rally 2017 will be held on Saturday, July ... Park Drive in Monroe (adjacent to the Louisiana Purchase Gardens & Zoo). , ... throughout Monroe. Citizens can turn in unregistered, illegally-held and imitation guns to law enforcement ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... pharmacies, has released an updated version of the HCV Treatment Path app (version ... chronic hepatitis C virus (HCV) infection. All of the latest HCV medications are ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... LAS VEGAS , July 13, 2017 It ... the United States is in the midst of ... Disease Control , since 1999, the number of overdose deaths ... , "resulting in over half a million dead from 2001 ... like codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a ...
(Date:7/13/2017)... York City-based market research firm Kalorama Information notes seven trends ... new products to new costs, to the threat of generic ... Potential Pipeline Disruptors . Among them are ... Age-Driven Growth - True Impact Moment Arriving   ... growing population and, to a more extreme extent, the aging ...
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known ... that can quantify biological aging in a precise manner using the myDNAge ... Steve Horvath , a professor of human genetics and biostatistics at the ... School of Public Health , Zymo Research,s proprietary DNAge ™ technology ... ...
Breaking Medicine Technology: